RhumbLine Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $677K | Sell |
192,934
-6,974
| -3% | -$28.6K | ﹤0.01% | 2420 |
|
|
2025
Q4 | $674K | Sell |
199,908
-23,321
| -10% | -$60.6K | ﹤0.01% | 2473 |
|
|
2025
Q3 | $292K | Buy |
223,229
+7,611
| +4% | +$7.88K | ﹤0.01% | 3013 |
|
|
2025
Q2 | $155K | Buy |
215,618
+7,575
| +4% | +$5.95K | ﹤0.01% | 3363 |
|
|
2025
Q1 | $306K | Sell |
208,043
-139,963
| -40% | -$333K | ﹤0.01% | 2879 |
|
|
2024
Q4 | $1.54M | Buy |
348,006
+10,041
| +3% | +$40.7K | ﹤0.01% | 2023 |
|
|
2024
Q3 | $1.39M | Sell |
337,965
-27,736
| -8% | -$149K | ﹤0.01% | 2092 |
|
|
2024
Q2 | $2.38M | Buy |
365,701
+2,577
| +0.7% | +$18.2K | ﹤0.01% | 1792 |
|
|
2024
Q1 | $3.16M | Sell |
363,124
-95,619
| -21% | -$1.16M | ﹤0.01% | 1668 |
|
|
2023
Q4 | $5.25M | Buy |
458,743
+507
| +0.1% | +$5.01K | 0.01% | 1380 |
|
|
2023
Q3 | $4.41M | Buy |
458,236
+3,935
| +0.9% | +$38.6K | 0.01% | 1433 |
|
|
2023
Q2 | $4.83M | Buy |
454,301
+38,476
| +9% | +$414K | 0.01% | 1396 |
|
|
2023
Q1 | $4.37M | Buy |
415,825
+15,766
| +4% | +$177K | 0.01% | 1405 |
|
|
2022
Q4 | $4.96M | Buy |
400,059
+10,219
| +3% | +$116K | 0.01% | 1282 |
|
|
2022
Q3 | $4.04M | Buy |
389,840
+78,396
| +25% | +$889K | 0.01% | 1356 |
|
|
2022
Q2 | $3.59M | Buy |
311,444
+146,836
| +89% | +$1.73M | 0.01% | 1445 |
|
|
2022
Q1 | $2.07M | Buy |
164,608
+6,277
| +4% | +$72K | ﹤0.01% | 1797 |
|
|
2021
Q4 | $1.85M | Sell |
158,331
-31,531
| -17% | -$387K | ﹤0.01% | 1930 |
|
|
2021
Q3 | $2.48M | Buy |
189,862
+6,173
| +3% | +$79.8K | ﹤0.01% | 1777 |
|
|
2021
Q2 | $2.36M | Sell |
183,689
-8,298
| -4% | -$95K | ﹤0.01% | 1873 |
|
|
2021
Q1 | $2.15M | Sell |
191,987
-10,418
| -5% | -$110K | ﹤0.01% | 1876 |
|
|
2020
Q4 | $2.31M | Sell |
202,405
-14,280
| -7% | -$156K | ﹤0.01% | 1783 |
|
|
2020
Q3 | $1.95M | Sell |
216,685
-63,085
| -23% | -$627K | ﹤0.01% | 1693 |
|
|
2020
Q2 | $2.89M | Buy |
279,770
+40,591
| +17% | +$415K | ﹤0.01% | 1516 |
|
|
2020
Q1 | $2.41M | Buy |
239,179
+19,417
| +9% | +$228K | 0.01% | 1449 |
|
|
2019
Q4 | $2.92M | Buy |
219,762
+5,195
| +2% | +$57.3K | ﹤0.01% | 1576 |
|
|
2019
Q3 | $1.84M | Buy |
214,567
+9,615
| +5% | +$93.4K | ﹤0.01% | 1785 |
|
|
2019
Q2 | $2.24M | Sell |
204,952
-15,448
| -7% | -$173K | ﹤0.01% | 1673 |
|
|
2019
Q1 | $2.5M | Sell |
220,400
-2,043
| -0.9% | -$22.8K | ﹤0.01% | 1581 |
|
|
2018
Q4 | $1.93M | Buy |
222,443
+73,244
| +49% | +$841K | ﹤0.01% | 1664 |
|
|
2018
Q3 | $2.31M | Sell |
149,199
-10,668
| -7% | -$169K | ﹤0.01% | 1578 |
|
|
2018
Q2 | $2.56M | Buy |
159,867
+7,445
| +5% | +$110K | 0.01% | 1534 |
|
|
2018
Q1 | $1.97M | Sell |
152,422
-3,368
| -2% | -$42K | ﹤0.01% | 1615 |
|
|
2017
Q4 | $1.96M | Sell |
155,790
-30,086
| -16% | -$393K | ﹤0.01% | 1635 |
|
|
2017
Q3 | $2.46M | Buy |
185,876
+1,793
| +1% | +$24.7K | 0.01% | 1482 |
|
|
2017
Q2 | $2.91M | Buy |
184,083
+4,433
| +2% | +$64.4K | 0.01% | 1338 |
|
|
2017
Q1 | $2.57M | Buy |
179,650
+7,923
| +5% | +$108K | 0.01% | 1404 |
|
|
2016
Q4 | $2.2M | Buy |
171,727
+8,622
| +5% | +$109K | 0.01% | 1387 |
|
|
2016
Q3 | $2.17M | Buy |
163,105
+3,388
| +2% | +$39.6K | 0.01% | 1349 |
|
|
2016
Q2 | $1.75M | Buy |
159,717
+9,369
| +6% | +$91.5K | 0.01% | 1436 |
|
|
2016
Q1 | $1.38M | Buy |
150,348
+2,632
| +2% | +$21.7K | ﹤0.01% | 1610 |
|
|
2015
Q4 | $1.43M | Buy |
147,716
+15,331
| +12% | +$148K | ﹤0.01% | 1569 |
|
|
2015
Q3 | $1.16M | Buy |
132,385
+3,017
| +2% | +$28.2K | ﹤0.01% | 1682 |
|
|
2015
Q2 | $1.31M | Sell |
129,368
-6,907
| -5% | -$80.3K | ﹤0.01% | 1695 |
|
|
2015
Q1 | $1.83M | Buy |
136,275
+24,459
| +22% | +$321K | 0.01% | 1459 |
|
|
2014
Q4 | $1.44M | Sell |
111,816
-4,649
| -4% | -$53.2K | ﹤0.01% | 1568 |
|
|
2014
Q3 | $1.26M | Sell |
116,465
-520
| -0.4% | -$5.95K | ﹤0.01% | 1604 |
|
|
2014
Q2 | $1.5M | Buy |
116,985
+19,879
| +20% | +$216K | ﹤0.01% | 1563 |
|
|
2014
Q1 | $1M | Sell |
97,106
-119
| -0.1% | -$1.34K | ﹤0.01% | 1799 |
|
|
2013
Q4 | $945K | Sell |
97,225
-597
| -0.6% | -$5.36K | ﹤0.01% | 1852 |
|
|
2013
Q3 | $971K | Sell |
97,822
-859
| -0.9% | -$8.43K | ﹤0.01% | 1800 |
|
|
2013
Q2 | $822K | Buy |
+98,681
| New | +$1.2M | ﹤0.01% | 1897 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
RhumbLine Advisers's IRWD Position: Q1 2026 in Review
RhumbLine Advisers reduced its Ironwood Pharmaceuticals (IRWD) stake by 3.5% in Q1 2026, selling an estimated $28.6K and leaving 192,934 shares worth $677K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.
RhumbLine Advisers first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.25M in Q4 2023. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- RhumbLine Advisers held 192,934 shares of Ironwood Pharmaceuticals worth $677K as of Q1 2026.
- RhumbLine Advisers sold 6,974 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $28.6K.
- Ironwood Pharmaceuticals made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #2420 holding.
- RhumbLine Advisers first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- RhumbLine Advisers's Ironwood Pharmaceuticals position peaked at $5.25M in Q4 2023.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.